Pharmacokinetic profile of cetuximab (Erbitux™) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma - Concepedia

Concepedia

Publication | Closed Access

Pharmacokinetic profile of cetuximab (Erbitux™) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma

80

Citations

22

References

2005

Year

Catherine Delbaldo, Jean‐Yves Pierga, Véronique Dièras, Sandrine Faivre, Valérie Laurence, Jean-Claude Vedovato, M. Bonnay, M. Mueser, Arno Nolting, Andreas Kovar,

European Journal of Cancer

OncologyPharmacokinetic ProfileMedicinePathologyAdvanced Egfr-positive AdenocarcinomaAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyMolecular Oncology

References

	Year	Citations

Page 1

Page 1